IRDOpus Genetics, Inc.

$3.46+77% 1Y

What is the market doing?

Mixed

No clear lean: nothing decisive, though a crowded short (+16% of shares).

1 to watch, 1 neutral, 1 without data
TrendRangeboundderived · Oct 23, 2026

Rangebound, no clear trend. Oversold (RSI 27). Price is −17% vs its 200-day average.

Short interest16% of sharesFINRA · Sep 30, 2026

A crowded short, settled Sep 30, 2026, about a week of normal trading to cover.

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How IRD is trading

Opus Genetics, Inc. is +77% over the past year while the S&P 500 is +16%: 61 points ahead of the market.

+77%

1-year return · S&P 500 +16%

vs 200-day average
−17%

vs 200-day average · a clear downtrend

RSI (14)
27

RSI (14) · oversold, sold harder than it has been bought

Below its 52-week high
43%

Below its 52-week high

Oct 21, 2024$0.71 – $6.09 · dashed line: 200-day averageOct 23, 2026
Details›
Last close2026-10-23
$3.46
1 monthS&P 500 −0.94%
−29%
1 yearS&P 500 +16%
+77%
5 yearsS&P 500 +86%
−19%
vs 50-day average$4.50
−23%
52-week high
$6.09
52-week low
$1.74
Annualised volatility
80%
Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
$7.6M
Calendar-year price return
YearReturn
2026 (year to date)+72%
2025+69%
2024−60%
2023−15%
2022−5.4%
2021−43%
2020−15%
2019−83%
2018−54%
2017+44%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan105 of 10+5.9%
Feb104 of 10+8.7%
Mar103 of 10+1.6%
Apr104 of 10−1.3%
May104 of 10−1.8%
Jun104 of 10−4.4%
Jul114 of 11−0.62%
Aug115 of 11−5.3%
Sep116 of 11+3.2%
Oct113 of 11−10%
Nov104 of 10+1.3%
Dec104 of 10−1.2%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

Where the price stands

Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.

What it has returned

With dividends, year by year, month by month, and by calendar month on average.